Clinical Review
Treatment Options for Symptomatic Degenerative Joint Disease Secondary to Legg-Calvé-Perthes Disease
Am J Orthop. 2011 January;40(1):E10-E13
Author and Disclosure Information
Dhana Kotilingam, MD, MS, David Sherlock, PhD, FRCS and Alexander Rosenstein, MD
Dr. Kotilingham is Research Fellow, Department of Orthopedic Surgery, University of Texas Health Science Center at Houston, Houston, Texas.
Dr. Sherlock is Consultant Surgeon in Orthopaedics and Trauma, Department of Orthopaedics, Royal Hospital for Sick Children, Glasgow, United Kingdom.
Dr. Rosenstein is Professor, Department of Orthopedic Surgery, University of Texas Health Science Center at Houston, Houston, Texas.
The treatment options for neglected Legg-Calvé-Perthes disease (LCPD) leading to symptomatic degenerative joint disease always have posed a challenge for the orthopedic surgeon. In addition, the literature is disorganized in this regard. Therefore, a structured literature review of the treatment options for the symptomatic sequelae of LCPD, especially in the context of joint replacement and resurfacing, is very much needed.